|
Market Closed -
Nasdaq
02:30:00 11/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 8.910 USD | -3.47% |
|
-1.76% | +8.92% |
| 27/10 | Wedbush Adjusts Price Target on ORIC Pharmaceuticals to $14 From $17, Keeps Outperform Rating | MT |
| 23/10 | ORIC Pharmaceuticals, Inc. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 96Cr | - | - | - | - | - |
| 6.82TCr | |||||
| 5.98TCr | |||||
| 5.61TCr | |||||
| 4.77TCr | |||||
| 4.6TCr |
Select your edition
All financial news and data tailored to specific country editions
